Astellas Pharma Inc
F:YPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Astellas Pharma Inc
F:YPH
|
JP |
|
S
|
Solaria Energia y Medio Ambiente SA
LSE:0KCD
|
ES |
|
QubicGames SA
F:QA7
|
PL |
|
W
|
Western Energy Services Corp
OTC:WEEEF
|
CA |
|
E
|
Enlivex Therapeutics Ltd
F:1BT
|
IL |
|
M
|
Majuba Hill Copper Corp
F:4NP
|
CA |
|
Nuformix PLC
F:1RT
|
UK |
|
M
|
Mynaric AG
XMUN:M0YN
|
DE |
|
A
|
Arcadium Lithium PLC
F:7WO0
|
IE |
|
R
|
Revival Gold Inc
F:76V
|
CA |
|
TZ Ltd
OTC:TZLTF
|
AU |
|
Wide Open Agriculture Ltd
F:2WO
|
AU |
|
I
|
Ingevity Corp
F:IGX
|
US |
|
Scinai Immunotherapeutics Ltd
F:2F5
|
IL |
|
Q
|
Quebec Nickel Corp
F:7IB
|
CA |
|
T
|
Transcontinental Inc
OTC:TCLCF
|
CA |
|
Pro DV AG
F:PDA
|
DE |
|
Belluna Co Ltd
F:73L
|
JP |
|
L
|
LiqTech International Inc
F:39J
|
DK |
|
First Pacific Co Ltd
F:FPC
|
HK |
|
Highbank Resources Ltd
F:V7O0
|
CA |
|
Straits Trading Company Ltd
F:W2F
|
SG |
Wall St Price Targets
YPH Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for YPH is 9.83 EUR with a low forecast of 7.08 EUR and a high forecast of 12.99 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YPH's stock price target?
Price Target
9.83
EUR
According to Wall Street analysts, the average 1-year price target for YPH is 9.83 EUR with a low forecast of 7.08 EUR and a high forecast of 12.99 EUR.
What is the Revenue forecast for Astellas Pharma Inc?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -5%.
What is the Gross Profit forecast for Astellas Pharma Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is -2%.
What is the Pre-Tax Income forecast for Astellas Pharma Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 2 years is 9%.
What is the Net Income forecast for Astellas Pharma Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 5%.
